Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III, International, Multicenter, Randomized, Parallel-group, Endoscopist-blinded Non-inferiority Study of the Efficacy, Safety and Patient Acceptance of Mannitol Versus Plenvu® in Bowel Preparation for Elective Colonoscopy. CLEARWAY

NCT07465705 is registered in ClinicalTrials.gov with NTC srl as lead sponsor.

NCT NCT07465705
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07465705 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III, International, Multicenter, Randomized, Parallel-group, Endoscopist-blinded Non-inferiority Study of the Efficacy, Safety and Patient Acceptance of Mannitol Versus Plenvu® in Bowel Preparation for Elective Colonoscopy. CLEARWAY
Lead sponsor
NTC srl
Phase
Phase 3
Overall status
Recruiting
Start date
September 2, 2025
Completion date
June 30, 2026
Enrollment
412 (estimated)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

elective colonoscopy